High-Risk Neuroblastoma Chemotherapy Without G-CSF
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
- Status
- COMPLETED
- Phase
- PHASE1
Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Response-based Treatment of High-risk Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Trial of Anti-GD2 T-cells (1RG-CART)
- Status
- COMPLETED
- Phase
- PHASE1
Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow
- Status
- COMPLETED
- Phase
- PHASE2
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chidamide Plus R-CHOP in Elderly DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Reduced Chemotherapy in Low Risk DLBCL
- Status
- UNKNOWN
- Phase
- PHASE4
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1